Mercury-in-glass thermometer Medical Center and Las Piñas Hospital also made steps to ban the toxic chemical. The country was the first one to make a step to ban mercury from its health care system in Southeast Asia. Since European Union directive 2007/51/EC came into force on 3 April 2009, the UK Health Protection Agency (HPA) reported that mercury thermometers could no longer be sold to the general public. Shops holding stocks of unsold thermometers had to withdraw them from sale; mercury thermometers purchased before this date could be used without legal implications. The purpose of these restrictions is to protect the environment
Risk Evaluation and Mitigation Strategies clinicians or health care institutions to become certified prior to prescribing. 12% include only a "communication plan" REMS element which is informational in nature. These communication plans are typically composed of letters, websites, and fact sheets describing the specific safety risks identified in the REMS. 26% include only the "medication guide" REMS element. Risk Evaluation and Mitigation Strategies Risk Evaluation and Mitigation Strategies is a program of the US Food and Drug Administration for the monitoring of medications with a high potential for serious adverse effects. REMS applies only to specific prescription drugs, but can apply to brand name or